Search
for
Sort by
Research 481–510 of 1000+
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
- Post-finasteride syndrome
- Hair growth promotion by Necrostatin-1s
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- Chemotherapy-Induced Hair Loss: The Use of Biomarkers for Predicting Alopecic Severity and Treatment Efficacy
- Common urologic diseases in older men and their treatment: how they impact fertility
- An accessible pharmacodynamic transcriptional biomarker for notch target engagement
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Steroid Hormones
- Management of Toxicities of Targeted Therapies
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review
- Androgens and Parkinson’s disease: the role in humans and in experiment
- Alopecia Areata and Alopecia Areata Incognita
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Ca <sup>2+</sup> -mediated protein citrullination regulates proliferation in the regenerating and malignant CNS
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- DUTASTERIDE AS AN EFFECTIVE TREATMENT IN ANDROGENETIC ALOPECIA – A LITERATURE REVIEW
- Bioavailability File: Bicalutamide
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Medical Treatment of Alopecia
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Hormone Blocking Anticancer Drugs
- Abstracts
- Cytostatics and immunosuppressive drugs
- ς<sub>1</sub>Receptor-Related Neuroactive Steroids Modulate Cocaine-Induced Reward
- Most Baricitinib Responders Achieved Full Scalp Hair Regrowth: Findings from Adult and Paediatric BRAVE-AA Trials
- Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus